Meenu Chhabra Karson
Meenu is an accomplished life science executive with more than 20 years in biotech and pharma. She was CEO of Proteostasis and Allozyne, CBO of BioXell and VP BD&L at Novartis. She has been responsible for numerous successful public and private capital raises over $500M, including IPOs, and negotiated pharma deals with potential value greater than $2B